Abstract: A dressing is used for curing a wound, and includes a dressing body having a first plane to make contact with a wound of a patient and a second plane opposite to the first surface, a display unit provided on the second plane to display information, and having a flexibility, and a light irradiation device to apply light the wound of the patient. The light irradiation device includes a device board, at least one light emitting diode mounted on the device board, and a water-proof protective film provided on the light emitting diode to protect the light emitting diode.

Abstract: The present invention relates to a fast disintegrating granular hair cleansing composition in which a wet granulation process, which is a pharmaceutical preparation method, is introduced into a method for preparing a cleanser. The fast disintegrating granular hair cleansing composition is prepared by a wet granulation process so as to be readily disintegrated into granules by using small force, because of a low hardness thereof, and can easily form creamy foam since a large surface area comes into contact with water. In addition, portability, convenience of use and sanitation can be improved when molding is carried out in a single-dose in which the entire amount is used at one time.

Abstract: Disclosed is a nozzle device and a minimally invasive injection device, and the nozzle device for a minimally invasive injection device according to an exemplary embodiment includes an outlet to generate a microjet of a liquid, and an injection part of a micro-scale size connected to the outlet and adapted to be inserted into a skin tissue to a preset depth.

Abstract: One aspect of the present invention relates to an effervescent tablet comprising a water-soluble lubricating agent, and a carbonated water cosmetic composition enabled to be used together therewith. One aspect of the present invention relates to an effervescent tablet comprising a crystalline #-hydroxy acid and a water-soluble lubricating agent, and a cosmetic composition using a skin toner for preventing the tablet from floating and allowing the tablet to rapidly form carbon dioxide gas in the cosmetic composition so as to maximize the visual effect and also the effect of carbon dioxide, thereby showing skin whitening, brightening and moisturizing effects and improving the pores.

Abstract: A flexible supercapacitor, a method of manufacturing the same, and a device including the same are provided, the flexible supercapacitor includes a first flexible electrode assembly, a second flexible electrode assembly corresponding to the first flexible electrode assembly, a separator for preventing contact between the first flexible electrode assembly and the second flexible electrode assembly, and an electrolyte between the first flexible electrode assembly and the second flexible electrode assembly. The flexible supercapacitor may include a tube including the first flexible electrode assembly, the second flexible electrode assembly, the separator, and the electrolyte.

Abstract: A medicinal fluid injection device for injecting a medicinal fluid into the skin of a patient so as to induce collagen generation and skin regeneration according to the radial diffusion of the medicinal fluid. The device includes a case part constituting the appearance; a medicinal fluid placing part mounted on the case part and in which a storage container storing a medicinal fluid is mounted; a medicinal fluid supply part connected to the storage container so as to supply a medicinal fluid; a medicinal fluid pressurization part mounted on the case part, and connected to the medicinal fluid supply part so as to pressurize the supplied medicinal fluid; and a medicinal fluid discharge part mounted on the medicinal fluid supply part so as to inject the medicinal fluid supplied from the medicinal fluid supply part.

Abstract: One aspect of the present invention relates to an effervescent tablet comprising a water-soluble lubricating agent, and a carbonated water cosmetic composition enabled to be used together therewith. One aspect of the present invention relates to an effervescent tablet comprising a crystalline #-hydroxy acid and a water-soluble lubricating agent, and a cosmetic composition using a skin toner for preventing the tablet from floating and allowing the tablet to rapidly form carbon dioxide gas in the cosmetic composition so as to maximize the visual effect and also the effect of carbon dioxide, thereby showing skin whitening, brightening and moisturizing effects and improving the pores.

Abstract: An apparatus for generating and storing electric energy, the apparatus including a fiber, an electric energy generation unit disposed on the fiber, and an electric energy storage unit disposed on the fiber.

Abstract: Disclosed is a nozzle device and a minimally invasive injection device, and the nozzle device for a minimally invasive injection device according to an exemplary embodiment includes an outlet to generate a microjet of a liquid, and an injection part of a micro-scale size connected to the outlet and adapted to be inserted into a skin tissue to a preset depth.

Abstract: Disclosed herein is a method of preparing a surface-modified inorganic filler, comprising the steps of: drying an inorganic filler; treating the inorganic filler with fluorine-containing gas to bond fluorine (F) to a part of the surface of the inorganic filler; and bonding a functional group-bonded silane coupling agent to another part of the surface of the inorganic filler, this other part of the surface thereof being not bonded with fluorine.

Abstract: This invention relates to a resin composition with good workability, including a liquid crystal oligomer, an epoxy resin, or a resin mixture thereof, and an inorganic filler having a nanocone shape, and to an insulating film for a printed circuit board, and a prepreg, which are manufactured using the resin composition.

Abstract: An apparatus for generating and storing electric energy, the apparatus including a fiber, an electric energy generation unit disposed on the fiber, and an electric energy storage unit disposed on the fiber.

Abstract: A flexible supercapacitor, a method of manufacturing the same, and a device including the same are provided, the flexible supercapacitor includes a first flexible electrode assembly, a second flexible electrode assembly corresponding to the first flexible electrode assembly, a separator for preventing contact between the first flexible electrode assembly and the second flexible electrode assembly, and an electrolyte between the first flexible electrode assembly and the second flexible electrode assembly. The flexible supercapacitor may include a tube including the first flexible electrode assembly, the second flexible electrode assembly, the separator, and the electrolyte.

Abstract: Disclosed is a controlled-release microparticle: including a matrix comprising a pharmacologically active component; and a controlled-release layer comprising a substance which forms a controlled-release stratum on the matrix. The disclosed controlled-release microparticle not only allows effective dual release control of a drug but can also exhibit outstanding dissolution characteristics even when a small amount of coating substance is used.

Abstract: Disclosed are a method for preparing a powder containing a nanoparticulated sparingly soluble drug, a powder prepared thereby, and a pharmaceutical composition containing the same. The disclosed method includes: providing a uniformly dispersed solution of a sparingly soluble drug which is formed into nanoparticles in the presence of a surface stabilizer; mixing the uniformly dispersed solution with a water-soluble dispersant solution; and drying the mixed solution to obtain the powder. When the powder containing the nanoparticulated sparingly soluble drug obtained by the disclosed method is redispersed in an aqueous solution, the sparingly soluble drug retains a particle size in the nano scale while the solubility and the dissolution rate of the drug are increased, thereby providing enhanced bioavailability. Consequently, the present disclosure can be useful in the development of preparations of a sparingly soluble drug for oral or parenteral administration.

Abstract: This present invention relates to novel compounds, isomer thereof or pharmaceutically acceptable salts thereof as vanilloid receptor (Vanilloid Receptor 1; VR1; TRPV1) antagonist; and a pharmaceutical composition containing the same. The present invention provides a pharmaceutical composition for preventing or treating a disease such as pain, migraine, arthralgia, neuralgia, neuropathies, nerve injury, skin disorder, urinary bladder hypersensitiveness, irritable bowel syndrome, fecal urgency, a respiratory disorder, irritation of skin, eye or mucous membrane, stomach-duodenal ulcer, inflammatory diseases, ear disease, and heart disease.

Abstract: A data driver and a method of driving the same. The data driver includes a shift register for generating sampling signals; sampling latches for sampling digital data applied to output channels, respectively, in accordance with the sampling signals; holding latch units for receiving the sampled digital data of the channels from the sampling latches to hold the digital data for a first period; first digital-to-analog converters for receiving the held digital data of the channels from the holding latch units to generate currents corresponding to the digital data; a second digital-to-analog converter commonly connected to the channels and the first digital-to-analog converters to receive the digital data provided from the holding latch units for a second period and to generate correction currents for the data currents; and output stages for sampling, correcting, and driving final currents using the data currents and the correction currents.

Abstract: The present invention relates to a controlled-release formulation comprising cilostazol and a method for preparing said formulation. The inventive controlled-release formulation comprising cilostazol or a pharmaceutically acceptable salt thereof, a solubilizing agent, a swelling agent, a swell-controlling agent and a gas generating material has advantages in that it maintains a constant cilostazol level in the blood through a slow release while it resides in the stomach and intestines over a long period of time, thereby increasing the absorption of cilostazol in the small intestine, the major absorption site of cilostazol, as well as minimizing adverse effects caused by rapid release and making it easy for a patient to take the drug.